The Marque The Marque

Oliver Motisi

Advisor & Investor | Health & Wellness

Dubai, UAE • London, UK


Oliver Motisi
David Moross
HighPost Capital
Brett Mufson
Fontainebleau Development

Oliver Motisi’s Biography

Oliver Motisi is an active advisor and investor into the health and wellness sector, and a consumer health executive and nutrition specialist with expertise in personalised nutrition, digital health, biomarker science, and health technology.

He was the CEO of Bioniq, a personalised nutrition company that combines blood biomarker analysis with artificial intelligence to deliver tailored supplementation programmes. Having joined Bioniq as an early member of the leadership team, he previously served as Chief Product Officer and UK Managing Director before becoming CEO, leading the company through its expansion, investment by Cristiano Ronaldo, and acquisition by Herbalife in a deal worth more than $150 million. He was also a Director of Bioniq Health-Tech Solutions Limited.

Before joining Bioniq, Oliver built his career across clinical nutrition, healthcare, and elite sport. He was Head of Sports & Exercise Nutrition and Clinical Rehabilitation Specialist at Lanserhof, where he developed nutrition and rehabilitation programmes with leading orthopaedic specialists for high-performance...
Oliver Motisi is an active advisor and investor into the health and wellness sector, and a consumer health executive and nutrition specialist with expertise in personalised nutrition, digital health, biomarker science, and health technology.

He was the CEO of Bioniq, a personalised nutrition company that combines blood biomarker analysis with artificial intelligence to deliver tailored supplementation programmes. Having joined Bioniq as an early member of the leadership team, he previously served as Chief Product Officer and UK Managing Director before becoming CEO, leading the company through its expansion, investment by Cristiano Ronaldo, and acquisition by Herbalife in a deal worth more than $150 million. He was also a Director of Bioniq Health-Tech Solutions Limited.

Before joining Bioniq, Oliver built his career across clinical nutrition, healthcare, and elite sport. He was Head of Sports & Exercise Nutrition and Clinical Rehabilitation Specialist at Lanserhof, where he developed nutrition and rehabilitation programmes with leading orthopaedic specialists for high-performance and post-surgical clients. Earlier, he was a Sports Nutritionist with Saracens Rugby Club, supporting professional athletes with performance nutrition and recovery.

Beyond his executive responsibilities, Oliver has served as a Director of VAHA Technologies Ltd, now part of the Bioniq Group. He advises companies across international markets on health technology, personalised nutrition, and product strategy, including Kayanee, a Public Investment Fund-backed women's wellbeing company, while supporting early-stage ventures as an Expert in Residence. He has also guest lectured MBA students at Imperial Business School and is a regular contributor to GQ Middle East on consumer health and wellbeing.

Oliver holds a Master of Science (MSc) in Clinical and Public Health Nutrition from University College London and a Bachelor of Science (BSc) in Sport Science from Brunel University.
READ MORE VIEW LESS

Oliver Motisi’s Background

Advisor & Investor logo Advisor & Investor logo
Advisor & Investor
Active Advisor & Investor | Health & Wellness Sector
Sep 2026 - Present
Dubai, AE
Oliver is an active advisor and investor across the health and wellness sector.
 
Bioniq
Chief Executive Officer
Jul 2025 - Sep 2026
London, UK
Bioniq is a personalised health technology company that combines blood biomarker analysis, artificial intelligence, and scientific research to create tailored nutritional supplements aligned with an individual's health profile and goals. In 2026, Bioniq entered a new phase of growth following Herbalife's acquisition of most of Bioniq’s core personalised nutrition business, expanding the platform's reach through Herbalife's global distribution network.
 
View all Hide

Oliver Motisi’s Gallery

Current Board Positions

Bioniq
Director | Bioniq Health-Tech Solutions Ltd.
Jan 2023 - Present
London, UK
Bioniq Health-Tech Solutions Limited is the UK operating company for Bioniq, a London-founded health technology business. Bioniq develops personalised nutritional supplements. These are based on individual health data, blood biomarkers, lifestyle information, and proprietary algorithms. The company combines digital health, nutrition science, and artificial intelligence to deliver customised micronutrient formulations for consumers, athletes, and corporate clients.
 
Bioniq
Board Member
Jan 2024 - Present
London, UK
 

Previous Board Positions

Bioniq
Director of the Board | VAHA Technologies Ltd.
Jan 2023 - Sep 2026
London, UK
As a Director of VAHA Technologies Ltd, which became part of the Bioniq Group, Oliver has contributed to the strategic oversight and governance of a business specialising in digital health, connected fitness, and consumer wellness technologies.
 

Previous Advisory Roles

Kayanee
Advisor & Consultant
Jul 2023 - Jul 2024
Riyadh, SA
Kayanee is a women's wellness company established by Saudi Arabia's Public Investment Fund (PIF). It provides integrated health, fitness, nutrition, beauty, and lifestyle services. Through digital platforms and in-person experiences, Kayanee supports Saudi Vision 2030 by promoting preventative health, active living, and greater participation in the Kingdom's growing wellness economy.
 
Aira Sciences | Previously: Sierra Medical
Strategic Advisor (Contract)
Sep 2021 - Mar 2022
London, UK
AIRA Sciences, formerly Sierra Medical, is a healthcare technology company. It develops artificial intelligence and infrared spectroscopy-based diagnostics to improve the early detection of diseases, including cancer. Its platform analyses molecular signatures from non-invasive biological samples to provide accessible, scalable screening tools designed to support earlier diagnosis and better patient outcomes.
 
View all Hide

Media

Article | Cristiano Ronaldo has officially invested in Bioniq!
Article
Jun 2025
Oliver discusses Bioniq's partnership with Cristiano Ronaldo, explaining how the investment reflects a shared commitment to personalised health and performance optimisation. He also explores the company's mission to advance biomarker-driven nutrition and the growing role of personalised health in helping individuals better understand and support their long-term wellbeing.
 
Health Optimisation Summit
Attendees | Bioniq
Apr 2023
London, UK
The Health Optimisation Summit is a global conference focused on the latest developments in longevity, preventive health, nutrition, fitness, and performance, bringing together clinicians, researchers, entrepreneurs, and health technology leaders. The event features expert-led presentations and discussions on evidence-based approaches to improving healthspan, human performance, and personalised wellbeing through advances in science, medicine, and innovation.
 

Interviews

Medium
Interviewee | Authority Magazine | Why Prioritizing Self-Care Is No Longer Optional for High-Performing Leaders
Apr 2026
Oliver's thoughts on why sustainable leadership depends on prioritising health and wellbeing, drawing on his experience in personalised nutrition, biomarker science, and business leadership. He explores how sleep, recovery, nutrition, and data-driven health insights contribute to better decision-making, stronger organisational culture, and long-term executive performance.
 

Speaking Engagements

Instagram | L'Officiel Arabia
Speaker
Mar 2026
Oliver explores the foundations of long-term health, explaining how sleep, nutrition, movement, and recovery work together to support biological regulation. He discusses why sustainable wellness is built on consistent daily habits and how optimising these four pillars can improve overall health and performance.
 
Imperial Business School logo Imperial Business School logo
Imperial Business School
Guest Lecturer | Psychology of Sales
Jun 2026
London, UK
Oliver has guest lectured MBA students at Imperial Business School on the psychology of sales and consumer trust, becoming the youngest guest lecturer to address the programme. Drawing on his experience at Bioniq, he explored how organisations can use data, technology, and personalised customer engagement to build trust at scale while maintaining meaningful human connections.
 

Oliver Motisi’s Education

Brunel University
Bachelor of Science (BSc) | Sport Science
University College London
Master of Science (MSc) | Clinical & Public Health Nutrition